Intestinal tumor in a dish

Yuki Ohta, Toshiro Sato

Research output: Contribution to journalShort survey

9 Citations (Scopus)

Abstract

Predicting the response of colorectal cancer (CRC) tumors to novel chemotherapeutic agents is significantly complicated by their underlying genetic and epigenetic diversity. Large-scale clinical trials involving thousands of patients are often necessary in order to accurately determine efficacy during drug development. Recent advances in genetic sequencing has allowed us to improve the prediction of drug response through genetic stratification of patients into smaller populations, yet the complexity of the cancer genome still often confounds accuracy of drug response prediction. Ultimately, we may need to replicate patient's own tumor in a dish in order to test drug responses so that the optimal treatment can be identified. We recently developed highly efficient and tractable organoid culture system for intestinal stem cells, in which single stem cells form 3D structures recapitulating original tissue architecture. This technology has also been applied to colorectal tumors and enables us to monitor the growth and response of the patient's own tumors. In this review, we provide an overview focusing on CRC organoid culture and its perspective for clinical applications.

Original languageEnglish
Article number14
JournalFrontiers in Medicine
Volume1
Issue numberMAY
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Colorectal Neoplasms
Organoids
Pharmaceutical Preparations
Neoplasms
Stem Cells
Epigenomics
Clinical Trials
Genome
Technology
Growth
Population
Therapeutics

Keywords

  • Colorectal cancers
  • Intestinal stem cells
  • Organoids
  • Personalized medicine
  • Wnt proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Intestinal tumor in a dish. / Ohta, Yuki; Sato, Toshiro.

In: Frontiers in Medicine, Vol. 1, No. MAY, 14, 01.01.2014.

Research output: Contribution to journalShort survey

Ohta, Yuki ; Sato, Toshiro. / Intestinal tumor in a dish. In: Frontiers in Medicine. 2014 ; Vol. 1, No. MAY.
@article{93c0a894cb634b9ba1ad25b89e789a66,
title = "Intestinal tumor in a dish",
abstract = "Predicting the response of colorectal cancer (CRC) tumors to novel chemotherapeutic agents is significantly complicated by their underlying genetic and epigenetic diversity. Large-scale clinical trials involving thousands of patients are often necessary in order to accurately determine efficacy during drug development. Recent advances in genetic sequencing has allowed us to improve the prediction of drug response through genetic stratification of patients into smaller populations, yet the complexity of the cancer genome still often confounds accuracy of drug response prediction. Ultimately, we may need to replicate patient's own tumor in a dish in order to test drug responses so that the optimal treatment can be identified. We recently developed highly efficient and tractable organoid culture system for intestinal stem cells, in which single stem cells form 3D structures recapitulating original tissue architecture. This technology has also been applied to colorectal tumors and enables us to monitor the growth and response of the patient's own tumors. In this review, we provide an overview focusing on CRC organoid culture and its perspective for clinical applications.",
keywords = "Colorectal cancers, Intestinal stem cells, Organoids, Personalized medicine, Wnt proteins",
author = "Yuki Ohta and Toshiro Sato",
year = "2014",
month = "1",
day = "1",
doi = "10.3389/fmed.2014.00014",
language = "English",
volume = "1",
journal = "Frontiers in Medicine",
issn = "2296-858X",
publisher = "Frontiers Media S. A.",
number = "MAY",

}

TY - JOUR

T1 - Intestinal tumor in a dish

AU - Ohta, Yuki

AU - Sato, Toshiro

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Predicting the response of colorectal cancer (CRC) tumors to novel chemotherapeutic agents is significantly complicated by their underlying genetic and epigenetic diversity. Large-scale clinical trials involving thousands of patients are often necessary in order to accurately determine efficacy during drug development. Recent advances in genetic sequencing has allowed us to improve the prediction of drug response through genetic stratification of patients into smaller populations, yet the complexity of the cancer genome still often confounds accuracy of drug response prediction. Ultimately, we may need to replicate patient's own tumor in a dish in order to test drug responses so that the optimal treatment can be identified. We recently developed highly efficient and tractable organoid culture system for intestinal stem cells, in which single stem cells form 3D structures recapitulating original tissue architecture. This technology has also been applied to colorectal tumors and enables us to monitor the growth and response of the patient's own tumors. In this review, we provide an overview focusing on CRC organoid culture and its perspective for clinical applications.

AB - Predicting the response of colorectal cancer (CRC) tumors to novel chemotherapeutic agents is significantly complicated by their underlying genetic and epigenetic diversity. Large-scale clinical trials involving thousands of patients are often necessary in order to accurately determine efficacy during drug development. Recent advances in genetic sequencing has allowed us to improve the prediction of drug response through genetic stratification of patients into smaller populations, yet the complexity of the cancer genome still often confounds accuracy of drug response prediction. Ultimately, we may need to replicate patient's own tumor in a dish in order to test drug responses so that the optimal treatment can be identified. We recently developed highly efficient and tractable organoid culture system for intestinal stem cells, in which single stem cells form 3D structures recapitulating original tissue architecture. This technology has also been applied to colorectal tumors and enables us to monitor the growth and response of the patient's own tumors. In this review, we provide an overview focusing on CRC organoid culture and its perspective for clinical applications.

KW - Colorectal cancers

KW - Intestinal stem cells

KW - Organoids

KW - Personalized medicine

KW - Wnt proteins

UR - http://www.scopus.com/inward/record.url?scp=84941788838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941788838&partnerID=8YFLogxK

U2 - 10.3389/fmed.2014.00014

DO - 10.3389/fmed.2014.00014

M3 - Short survey

VL - 1

JO - Frontiers in Medicine

JF - Frontiers in Medicine

SN - 2296-858X

IS - MAY

M1 - 14

ER -